Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 13/20 | 0.61 |
| ▸ | CTSB | P07858 | 7/20 | 0.61 |
| ▸ | CTSS | P25774 | 3/20 | 0.59 |
| ▸ | CTSK | P43235 | 3/20 | 0.59 |
| ▸ | CTSL | P07711 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.41 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.41 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7698259 | 0.92 | CAPN1 (0.61) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7689993 | 0.91 | CAPN1 (0.74) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7696527 | 0.90 | CAPN1 (0.65) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7690558 | 0.90 | CAPN1 (0.60) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7693912 | 0.89 | CAPN1 (0.73) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7694140 | 0.86 | CAPN1 (0.60) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7688501 | 0.85 | CAPN1 (0.58) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7690226 | 0.85 | CAPN1 (0.53) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7688889 | 0.85 | CAPN1 (0.53) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7696618 | 0.85 | CAPN1 (0.51) | CAPN1CTSBCTSSCTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |